Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Colorcon
Harvard Business School
Mallinckrodt
Medtronic

Last Updated: September 27, 2022

Fluocinolone acetonide; hydroquinone; tretinoin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for fluocinolone acetonide; hydroquinone; tretinoin and what is the scope of patent protection?

Fluocinolone acetonide; hydroquinone; tretinoin is the generic ingredient in one branded drug marketed by Galderma Labs Lp and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fluocinolone acetonide; hydroquinone; tretinoin has twenty-nine patent family members in eighteen countries.

One supplier is listed for this compound.

Summary for fluocinolone acetonide; hydroquinone; tretinoin
International Patents:29
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 3
DailyMed Link:fluocinolone acetonide; hydroquinone; tretinoin at DailyMed
Recent Clinical Trials for fluocinolone acetonide; hydroquinone; tretinoin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Galderma Laboratories, L.P.Phase 2
Pontificia Universidad Catolica de ChilePhase 2
Galderma Laboratories, L.P.Phase 4

See all fluocinolone acetonide; hydroquinone; tretinoin clinical trials

Pharmacology for fluocinolone acetonide; hydroquinone; tretinoin

US Patents and Regulatory Information for fluocinolone acetonide; hydroquinone; tretinoin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112-001 Jan 18, 2002 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112-001 Jan 18, 2002 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112-001 Jan 18, 2002 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112-001 Jan 18, 2002 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for fluocinolone acetonide; hydroquinone; tretinoin

Country Patent Number Title Estimated Expiration
Japan 2010280738 TOPICAL SKIN CARE COMPOSITION See Plans and Pricing
South Korea 100851789 See Plans and Pricing
South Korea 20060040755 TOPICAL SKIN CARE COMPOSITION See Plans and Pricing
Japan 5528973 See Plans and Pricing
South Korea 20050083828 TOPICAL SKIN CARE COMPOSITION See Plans and Pricing
European Patent Office 1562531 COMPOSITION DE SOIN POUR LA PEAU A APPLICATION TOPIQUE (TOPICAL SKIN CARE COMPOSITION) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for fluocinolone acetonide; hydroquinone; tretinoin

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2233112 132014902285293 Italy See Plans and Pricing PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Harvard Business School
Moodys
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.